Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LETREISE D WINKFIELD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1720095284
CMS profile
259551
Location
EDINBURG, TX

General Payments · PY2018–2024

$6,717.50

  • Reported across 455 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$285.09

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $285.09 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,451.59 115
PY2019 $1,103.49 83
PY2020 $1,397.11 87
PY2021 $1,099.05 74
PY2022 $799.99 49
PY2023 $581.18 31
PY2024 $285.09 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $23.94 01/12/2024 Food and Beverage Undisputed 01/23/2026 1139312146 CMS
Astellas Pharma US Inc $24.78 02/23/2024 Food and Beverage Undisputed 01/23/2026 1139313650 CMS
Axsome Therapeutics, Inc. $19.54 02/06/2024 Food and Beverage Undisputed 01/23/2026 1148299164 CMS
Axsome Therapeutics, Inc. $15.92 04/17/2024 Food and Beverage Undisputed 01/23/2026 1148299166 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.59 02/16/2024 Food and Beverage Undisputed 01/23/2026 1086238340 CMS
Boston Scientific Corporation $18.65 02/08/2024 Food and Beverage Undisputed 01/23/2026 1092640571 CMS
Esperion Therapeutics, Inc. $15.13 04/20/2024 Food and Beverage Undisputed 01/23/2026 1129460176 CMS
Esperion Therapeutics, Inc. $16.42 05/17/2024 Food and Beverage Undisputed 01/23/2026 1129460178 CMS
Lilly USA, LLC $14.07 01/19/2024 Food and Beverage Undisputed 01/23/2026 1135152932 CMS
Lilly USA, LLC $24.74 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135150700 CMS
Lilly USA, LLC $17.93 02/29/2024 Food and Beverage Undisputed 01/23/2026 1135088859 CMS
Novo Nordisk Inc $14.96 01/25/2024 Food and Beverage Undisputed 01/23/2026 1096617298 CMS
Novo Nordisk Inc $15.39 06/11/2024 Food and Beverage Undisputed 01/23/2026 1097159146 CMS
Phadia US Inc. $20.79 04/13/2024 Food and Beverage Undisputed 01/23/2026 1067582250 CMS
Phathom Pharmaceuticals, Inc. $13.15 02/02/2024 Food and Beverage Undisputed 01/23/2026 1151139879 CMS
Phathom Pharmaceuticals, Inc. $15.09 05/16/2024 Food and Beverage Undisputed 01/23/2026 1151139881 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.